Trine Marita Reine1, Ingrid Benedicte Moss Kolseth2, Astri Jeanette Meen2, Jørn Petter Lindahl3, Trond Geir Jenssen4, Finn Per Reinholt5, Joseph Zaia6, Chun Shao6, Anders Hartmann3, Svein Olav Kolset2. 1. Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway. Electronic address: t.m.reine@medisin.uio.no. 2. Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway. 3. Department of Transplant Medicine, Section of Nephrology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. 4. Department of Transplant Medicine, Section of Nephrology, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, Faculty of Health Science, University of Tromsø, Tromsø, Norway. 5. Department of Pathology, University of Oslo and Oslo University Hospital, Rikshospitalet, Oslo, Norway. 6. Department of Biochemistry, Boston University School of Medicine, Boston University Medical Campus, Boston, MA, USA.
Abstract
AIMS: Patients with type 1 diabetes and end-stage renal disease with simultaneous pancreas and kidney (SPK) or kidney transplants alone (KA) were recruited 9-12 years post transplantation. We investigated differences between these groups with regard to inflammatory parameters and long-term structural changes in kidneys. METHODS: Blood samples were analyzed by ELISA and multiplex for chemokines, cytokines, growth factors, cell adhesion molecules and matrix metalloproteinases. Kidney graft biopsies were analyzed by electron microscopy for glomerular basement membrane thickness. Heparan- and chondroitin sulfate disaccharide structures were determined by size exclusion chromatography mass-spectrometry. RESULTS: The SPK and the KA group had average glycated hemoglobin A1c (HbA1c) of 5.8% (40 mmol/mol) and 8.6% (70 mmol/mol) respectively. SPK recipients also had 16.2% lower body mass index (BMI) and 46.4% lower triglyceride levels compared with KA recipients, compatible with an improved metabolic profile in the SPK group. Plasminogen activator inhibitor (PAI-1), C-reactive protein (CRP) and vascular endothelial growth factor (VEGF) were lower in the SPK group. In kidney graft biopsies of the KA-patients an 81.2% increase in average glomerular basement membrane thickness was observed, accompanied by alterations in heparan sulfate proteoglycan structure. In addition to a decrease in 6-O-sulfated disaccharides, an increase in non-N-sulfated disaccharides with a corresponding slight decrease in N-sulfation was found in kidney biopsies from hyperglycemic patients. CONCLUSIONS: Patients with end stage renal disease subjected to KA transplantation showed impaired inflammatory profile, increased thickness of basement membranes and distinct changes in heparan sulfate structures compared with SPK recipients.
AIMS: Patients with type 1 diabetes and end-stage renal disease with simultaneous pancreas and kidney (SPK) or kidney transplants alone (KA) were recruited 9-12 years post transplantation. We investigated differences between these groups with regard to inflammatory parameters and long-term structural changes in kidneys. METHODS: Blood samples were analyzed by ELISA and multiplex for chemokines, cytokines, growth factors, cell adhesion molecules and matrix metalloproteinases. Kidney graft biopsies were analyzed by electron microscopy for glomerular basement membrane thickness. Heparan- and chondroitin sulfate disaccharide structures were determined by size exclusion chromatography mass-spectrometry. RESULTS: The SPK and the KA group had average glycated hemoglobin A1c (HbA1c) of 5.8% (40 mmol/mol) and 8.6% (70 mmol/mol) respectively. SPK recipients also had 16.2% lower body mass index (BMI) and 46.4% lower triglyceride levels compared with KA recipients, compatible with an improved metabolic profile in the SPK group. Plasminogen activator inhibitor (PAI-1), C-reactive protein (CRP) and vascular endothelial growth factor (VEGF) were lower in the SPK group. In kidney graft biopsies of the KA-patients an 81.2% increase in average glomerular basement membrane thickness was observed, accompanied by alterations in heparan sulfate proteoglycan structure. In addition to a decrease in 6-O-sulfated disaccharides, an increase in non-N-sulfated disaccharides with a corresponding slight decrease in N-sulfation was found in kidney biopsies from hyperglycemicpatients. CONCLUSIONS:Patients with end stage renal disease subjected to KA transplantation showed impaired inflammatory profile, increased thickness of basement membranes and distinct changes in heparan sulfate structures compared with SPK recipients.
Authors: Jacob van den Born; Brenda Pisa; Marinka A H Bakker; Johanna W A M Celie; Carin Straatman; Steven Thomas; Gian C Viberti; Lena Kjellen; Jo H M Berden Journal: J Biol Chem Date: 2006-08-01 Impact factor: 5.157
Authors: Craig Meagher; Guillermo Arreaza; Andrew Peters; Craig A Strathdee; Philippe A Gilbert; Qing-Sheng Mi; Pere Santamaria; Gregory A Dekaban; Terry L Delovitch Journal: Diabetes Date: 2007-03 Impact factor: 9.461
Authors: Tessa J M Wijnhoven; Joost F M Lensen; Angelique L W M M Rops; Johan van der Vlag; Svein O Kolset; Hans-Jacob Bangstad; Per Pfeffer; Mabel J W van den Hoven; Jo H M Berden; Lambert P W J van den Heuvel; Toin H van Kuppevelt Journal: Am J Kidney Dis Date: 2006-08 Impact factor: 8.860
Authors: Scott J Harvey; George Jarad; Jeanette Cunningham; Angelique L Rops; Johan van der Vlag; Jo H Berden; Marcus J Moeller; Lawrence B Holzman; Robert W Burgess; Jeffrey H Miner Journal: Am J Pathol Date: 2007-07 Impact factor: 4.307
Authors: Andrew Advani; Darren J Kelly; Suzanne L Advani; Alison J Cox; Kerri Thai; Yuan Zhang; Kathryn E White; Renae M Gow; Sally M Marshall; Brent M Steer; Philip A Marsden; P Elizabeth Rakoczy; Richard E Gilbert Journal: Proc Natl Acad Sci U S A Date: 2007-08-28 Impact factor: 11.205